Study record · Hexarelin
Hexarelin GH response in healthy men
Hexarelin produced dose-dependent GH release.
Key result
Hexarelin produced dose-dependent GH release.
Study details
Study designPlacebo-controlled dose-response study
PopulationHealthy men
Sample size12
RouteIntravenous
Regimen / exposure0.5, 1 or 2 micrograms/kg
DurationSingle-dose
ComparatorPlacebo / dose groups
Primary endpoint / questionGrowth-hormone response
Safety resultAcute endocrine study only.
Key limitationsVery small study; no evidence of improved body composition, recovery or longevity.
Registry / identifierPMID 7957536